Immunogenicity of Human papillomavirus vaccine in immunosuppressed children
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2016
At a glance
- Drugs Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Cervical cancer; Human papillomavirus infections
- Focus Adverse reactions; Pharmacodynamics
- 08 Jun 2016 Status changed from active, no longer recruiting to completed.
- 21 Nov 2013 Status changed from recruiting to active, no longer recruiting as reported by Australian New Zealand Clinical Trials Registry.
- 13 May 2009 New trial record